Development of an opioid-related Overdose Risk Behavior Scale (ORBS)

References

• Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors—United States, 2005–2013. Morb Mort Wkly Rep Surveill Summ. 2014;63(Suppl 4):3–27.
   PubMedGoogle Scholar
• Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend. 2013;131:263–270.
   PubMed Web of Science ®Google Scholar
• Lankenau SE, Teti M, Silva K, Bloom JJ, Harocopos A, Treese M. Patterns of prescription drug misuse among young injection drug users. J Urban Health. 2012;89:1004–1016.
   PubMed Web of Science ®Google Scholar
• Chen L, Hedegaard H, Warner M. QuickStats: rates of deaths from drug poisoning and drug poisoning involving opioid analgesics, United States, 1999–2013. MMWR Morb Mort Wkly Rep. 2015;64:32.
   Web of Science ®Google Scholar
• Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71:821–826.
   PubMed Web of Science ®Google Scholar
• Courtwright DT. Preventing and treating narcotic addiction—century of federal drug control. N Engl J Med. 2015;373:2095–2097.
   PubMed Web of Science ®Google Scholar
• Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure. Pain. 2007;130:144–156.
   PubMed Web of Science ®Google Scholar
• Finkelman MD, Kulich RJ, Zoukhri D, Smits N, Butler SF. Shortening the Current Opioid Misuse Measure via computer-based testing: a retrospective proof-of-concept study. BMC Med Res Methodol. 2013;13:126.
   PubMed Web of Science ®Google Scholar
• Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008;9:360–372.
   PubMed Web of Science ®Google Scholar
• Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006;32:287–293.
   PubMed Web of Science ®Google Scholar
• Larance B, Bruno R, Lintzeris N, et al. Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: the Opioid-Related Behaviours In Treatment (ORBIT) scale. Drug Alcohol Depend. 2016;159:42–52.
   Web of Science ®Google Scholar
• Banta-Green CJ, Merrill JO, Doyle SR, Boudreau DM, Calsyn DA. Measurement of opioid problems among chronic pain patients in a general medical population. Drug Alcohol Depend. 2009;104:43–49.
   PubMed Web of Science ®Google Scholar
• Adams LL, Gatchel RJ, Robinson RC, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage. 2004;27:440–459.
   PubMed Web of Science ®Google Scholar
• Jamison RN, Martel MO, Edwards RR, Qian J, Sheehan KA, Ross EL. Validation of a brief Opioid Compliance Checklist for patients with chronic pain. J Pain. 2014;15:1092–1101.
   PubMed Web of Science ®Google Scholar
• Compton PA, Wu SM, Schieffer B, Pham Q, Naliboff BD. Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance. J Pain Symptom Manage. 2008;36:383–395.
   PubMed Web of Science ®Google Scholar
• Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6:432–442.
   PubMed Web of Science ®Google Scholar
• Friedman R, Li V, Mehrotra D. Treating pain patients at risk: evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med. 2003;4:182–185.
   PubMed Web of Science ®Google Scholar
• Chabal C, Erjavec MK, Jacobson L, Mariano A, Chaney E. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain. 1997;13:150–155.
   PubMed Web of Science ®Google Scholar
• Wright N, Oldham N, Jones L. Exploring the relationship between homelessness and risk factors for heroin-related death—a qualitative study. Drug Alcohol Rev. 2005;24:245–251.
   PubMed Web of Science ®Google Scholar
• Binswanger IA, Nowels C, Corsi KF, et al. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addict Sci Clin Pract. 2012;7:3.
   PubMedGoogle Scholar
• Williams AV, Strang J, Marsden J. Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation. Drug Alcohol Depend. 2013;132:383–386.
   PubMed Web of Science ®Google Scholar
• Copeland LA, Finley EP, Bollinger MJ, Amuan ME, Pugh MJ. Comorbidity correlates of death among new veterans of Iraq and Afghanistan deployment. Med Care. 2016;54:1078–1081.
   PubMed Web of Science ®Google Scholar
• Bennett AS, Elliot L, Golub A. Veterans' health and opioid safety—contexts, risks, and outreach implications. Fed Pract. 2015;32:4–7.
   Google Scholar
• Bennett AS, Elliott L, Golub A, Pouget ER, Rosenblum A. Opioid use and overdose risk among OEF/OIF/OND era veterans: a mixed methods analysis. Drug Alcohol Depend. 2015;158:e18.
   Google Scholar
• Butler SF, Budman SH, Fanciullo GJ, Jamison RN. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin J Pain. 2010;26:770–776.
   PubMed Web of Science ®Google Scholar
• Bennett AS, Elliott L, Golub A, Pouget ER, Rosenblum A. Opioid use and overdose risk among OEF/OIF/OND era veterans: a mixed methods analysis. Presented at Annual Meeting of the College on Problems of Drug Dependence; June 13–18, 2015; Phoenix, Arizona.
   Google Scholar
• Furr RM, Bacharach VR. Psychometrics: An Introduction. 2nd ed. Los Angeles, CA: Sage; 2014.
   Google Scholar
• Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420–428.
   PubMed Web of Science ®Google Scholar
• Clark LA, Watson D. Constructing validity: basic issues in objective scale development. Psychol Assess. 1995;7:309–319.
   Web of Science ®Google Scholar
• Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths—United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2016;64:1378–1382.
   PubMed Web of Science ®Google Scholar
• Lake S, Hayashi K, Buxton J, et al. The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Drug Alcohol Depend. 2015;156:297–303.
   PubMed Web of Science ®Google Scholar
• Lake S, Wood E, Buxton J, Dong H, Montaner J, Kerr T. Prescription opioid use and non-fatal overdose in a cohort of injection drug users. Am J Drug Alcohol Abuse. 2015;41:257–263.
   PubMed Web of Science ®Google Scholar
• Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374:154–163.
   PubMed Web of Science ®Google Scholar
• Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125:8–18.
   PubMed Web of Science ®Google Scholar
• Han B, Compton WM, Jones CM, Cai R. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003–2013. JAMA. 2015;314:1468–1478.
   PubMed Web of Science ®Google Scholar
• Minett WJ, Moore TL, Juhascik MP, Nields HM, Hull MJ. Concentrations of opiates and psychotropic agents in polydrug overdoses: a surprising correlation between morphine and antidepressants. J Forensic Sci. 2010;55:1319–1325.
   PubMed Web of Science ®Google Scholar
• Jones C, Paulozzi LJ, Mack KA. Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse–related emergency department visits and drug-related deaths—United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63:881–885.
   PubMed Web of Science ®Google Scholar